FDA Clearance Tracker · P120006-S031
Alto Abdominal Stent Graft System
Last checked: Nov 20, 2026Latest source record: Mar 13, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Mar 13, 2020
Approved
Time to decision
366 days
Received Mar 13, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P120006-S031
- Device name
- Alto Abdominal Stent Graft System
- Applicant
- Endologix, LLC
- Applicant location
- Santa Rosa, CA
- Received
- Mar 13, 2019
- Decided
- Mar 13, 2020
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P120006
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Alto Abdominal Stent Graft System. The device is indicated for treatment of patients with infrarenal abdominal aortic aneurysms having the vascular morphology suitable for endovascular repair with the device, which includes the following:1) Adequate iliac/femoral access compatible with vascular access techniques (femoral cutdown or percutaneous), devices, and/or accessories;2) A proximal aortic landing zone for the sealing ring 7mm below the inferior renal artery; 3) An aortic sealing zone comprised of healthy aorta defined as; a. Lack of significant thrombus > 8 mm in thickness; at any point along the aortic circumference at the level of 7mm below the inferior renal artery; b. Lack of significant calcification at the level of 7mm below the inferior renal artery; c. Conicity < 10% as measured from the inferior renal artery to the aorta 7mm below the inferior renal artery; d. An inner wall diameter of no less than 16 mm and no greater than 30 mm at 7 mm below the inferior renal artery; and e. An aortic angle of <= 60 degrees. 4) A distal iliac landing zone: a. With a length of at least 10 mm; and b. With an inner wall diameter of no less than 8 mm and no greater than 25 mm.
Source documents
Other decisions for Endologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- DETOUR SystemBreakthroughPMA
P220021 · Decided Jun 7, 2023 · 239 days after receipt
Device type: Stent graft, bypass, superficial femoral artery (QWM) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.